Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA melamine alert

This article was originally published in The Tan Sheet

Executive Summary

On Nov. 12, FDA issued an import alert ordering all milk products, milk-derived ingredients and finished food products with milk from China be detained without physical examination due to the possible presence of melamine or melamine analogs. To secure release of shipments, importers must provide results of a third-party lab analysis verifying the absence of melamine and cyanuric acid, or documentation showing the product contains no milk or milk-derived ingredients. FDA also issued an interim safety and risk assessment of melamine in human food, saying in a Nov. 13 Federal Register notice it cannot establish a safe level of melamine and its analogues in infant formula. In foods for older children and adults, levels of melamine and melamine-related compounds below 2.4 ppm do not raise public health concerns, FDA says. The agency adds it does not approve melamine use in direct addition to food or as a fertilizer in the U.S. Comments on the paper, which was drafted after melamine-tainted infant formula caused 13,000 hospitalizations and three deaths. Comments are due Jan. 12 (1"The Tan Sheet" Sept. 15, 2008, In Brief)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102307

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel